BOOKS BY CATEGORY
Your Account
Authorized Generic Drugs
Short & Long-Term Competitive Effects
Price
Quantity
£266.99
(To see other currencies, click on price)
Hardback
Add to basket  

MORE ABOUT THIS BOOK

Main description:

Rising health care costs have for many years focused congressional attention upon the development and availability of prescription drugs. Recently, the presence of "authorised generic" pharmaceuticals in the drug marketplace has been the subject of congressional concern. An "authorised generic" is a pharmaceutical that is marketed by or on behalf of a brand-named drug company, but is sold under a generic name. The brand-name firm may distribute the drug under its own auspices or via a license to a generic drug company. The price of this "authorised copy" is ordinarily lower than that of the brand-name drug. Some sources refer to authorised generics as "branded," "flanking," or "pseudo" generics." This book presents an analysis of the innovation and public health issues relating to authorised generic drugs beginning with a review of the procedures through which independent generic drug companies receive government permission to market their products and resolve patent disputes with brand-name firms and consumer welfare.


Contents:

Preface; Authorized Generic Drugs: Short-Term Effects & Long-Term Impact; Authorized Generic Pharmaceuticals: Effects on Innovation; Index.


PRODUCT DETAILS

ISBN-13: 9781622570751
Publisher: Nova Science Publishers Inc
Publication date: November, 2012
Pages: 216
Weight: 560g
Availability: Contact supplier
Subcategories: Pharmacology

CUSTOMER REVIEWS

Average Rating